IBJNews

Indiana's life sciences industry sees trouble ahead

Back to TopCommentsE-mailPrintBookmark and Share

Long sold as one of the state's brightest economic hopes, Indiana's life sciences industry has weathered the recession relatively well.

Total employment is up nearly 7 percent and major investment announcements are trickling in.

Signs of trouble, however, loom. Indianapolis-based Eli Lilly and Co., arguably Indiana's life sciences engine, continues to shed jobs. The state government's direct investments into the industry's smallest companies are down.

And, perhaps most ominously, tighter capital markets threaten to starve the risky process of medical innovation.

"That is the legacy of this recession. Not one or two missed companies, but a changed capital market," said David Johnson, president and CEO of BioCrossroads, a statewide life sciences organization.

"The challenges of getting capital are going to be permanently harder."

At the moment, however, the industry is still producing new jobs.

Statewide, life sciences employment is up 6.5 percent since the recession hit, according to data from the U.S. Bureau of Labor Statistics. The bureau tracks the medical supplies manufacturing as well as medical and diagnostic laboratories sectors.

More Hoosiers were working in those sectors in August 2010, 26,200 people, than at any time in the last decade, the data shows.

More jobs could be coming, too.

This summer, several life science firms across the state announced significant investment plans.

In Warsaw, orthopedic device manufacturer Biomet Inc., will invest $26 million and create 280 jobs, officials have said.

In Indianapolis, Beckman Coulter plans to spend $18.2 million and create 95 jobs. In Greenwood, Advantis Medical intends to add 100 positions with a $6 million expansion.

In early 2010, a $85 million manufacturing facility opened by Cook Pharmica in Bloomington created more than 100 jobs.

While many of the mid-size firms are expanding, Indiana's life sciences giant is pulling back.

Lilly is in the midst of the largest restructuring in its 134-year history, and aims to cut 5,500 jobs worldwide and $1 billion in annual costs by December.

The hope among business leaders is that former Lilly employees in Indiana stay here, and join other life sciences companies.

"The goal is 'brain neutral,' not 'brain drain,'" Bart Peterson, a senior vice president with Lilly and a former mayor of Indianapolis, said this summer.

An important part of that effort is funding startups, experts said. The state's 21st Century Fund tries to do exactly that, offering early-stage investments to promising young companies.

However, the fund's investments in the life sciences have steadily fallen during the recession — from $14.6 million in 2007-2008 to just $6.6 million in 2009-2010 — even as normal venture capital also disappears.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. With Pence running the ship good luck with a new government building on the site. He does everything on the cheap except unnecessary roads line a new beltway( like we need that). Things like state of the art office buildings and light rail will never be seen as an asset to these types. They don't get that these are the things that help a city prosper.

  2. Does the $100,000,000,000 include salaries for members of Congress?

  3. "But that doesn't change how the piece plays to most of the people who will see it." If it stands out so little during the day as you seem to suggest maybe most of the people who actually see it will be those present when it is dark enough to experience its full effects.

  4. That's the mentality of most retail marketers. In this case Leo was asked to build the brand. HHG then had a bad sales quarter and rather than stay the course, now want to go back to the schlock that Zimmerman provides (at a considerable cut in price.) And while HHG salesmen are, by far, the pushiest salesmen I have ever experienced, I believe they are NOT paid on commission. But that doesn't mean they aren't trained to be aggressive.

  5. The reason HHG's sales team hits you from the moment you walk through the door is the same reason car salesmen do the same thing: Commission. HHG's folks are paid by commission they and need to hit sales targets or get cut, while BB does not. The sales figures are aggressive, so turnover rate is high. Electronics are the largest commission earners along with non-needed warranties, service plans etc, known in the industry as 'cheese'. The wholesale base price is listed on the cryptic price tag in the string of numbers near the bar code. Know how to decipher it and you get things at cost, with little to no commission to the sales persons. Whether or not this is fair, is more of a moral question than a financial one.

ADVERTISEMENT